Cargando…

Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans

Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used for the treatment of type 2 diabetes, with additional beneficial effects for the kidney. Treatment of mice with linagliptin revealed increased storage of cobalamin (Cbl, Vitamin B12) in organs if a standard Cbl diet (30 µg Cbl/kg chow) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tammen, Harald, Kömhoff, Martin, Delić, Denis, Lund, Søren S., Hocher, Berthold, Frankenreiter, Sandra, Hess, Rüdiger, von Eynatten, Maximilian, Mark, Michael, Klein, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837112/ https://www.ncbi.nlm.nih.gov/pubmed/36635409 http://dx.doi.org/10.1038/s41598-023-27648-7

Ejemplares similares

Correlation between maternal and childhood VitB12, folic acid and ferritin levels
por: Zeeshan, Fatima, et al.
Publicado: (2017)

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria
por: Cooper, Mark E., et al.
Publicado: (2019)

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013)

Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy
por: Delić, Denis, et al.
Publicado: (2020)

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA‐T2D trial
por: Groop, Per‐Henrik, et al.
Publicado: (2017)

Analysis of Cobalamin (Vit B12) in Ripened Cheese by Ultra-High-Performance Liquid Chromatography Coupled with Mass Spectrometry
por: Rampazzo, Giulia, et al.
Publicado: (2022)

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
por: Hansen, Henrik H., et al.
Publicado: (2021)

Primary Lamellar Macular Holes: To Vit or Not to Vit
por: Wu, Lihteh, et al.
Publicado: (2022)

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
por: Groop, Per-Henrik, et al.
Publicado: (2013)

A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors
por: Venkatramani, Rajkumar, et al.
Publicado: (2013)

Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials
por: von Eynatten, Maximilian, et al.
Publicado: (2013)

Cobalamin Deficiency: Effect on Homeostasis of Cultured Human Astrocytes
por: Rzepka, Zuzanna, et al.
Publicado: (2019)

25(OH)VitD and human endocrine and functional fertility parameters in women undergoing IVF/ICSI
por: Tian, Mei, et al.
Publicado: (2022)

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
por: Johansen, Odd Erik, et al.
Publicado: (2012)

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial
por: Ma, Ronald CW, et al.
Publicado: (2017)

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment
por: Groop, P-H, et al.
Publicado: (2014)

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials
por: Davidson, Jaime A, et al.
Publicado: (2014)

Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency
por: Obeid, Rima, et al.
Publicado: (2015)

Review of cobalamin status and disorders of cobalamin metabolism in dogs
por: Kather, Stefanie, et al.
Publicado: (2019)

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study
por: McGill, Janet B., et al.
Publicado: (2013)

Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study
por: Haak, T, et al.
Publicado: (2013)

Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis
por: Gülsen, Askin, et al.
Publicado: (2021)

Gait-ViT: Gait Recognition with Vision Transformer
por: Mogan, Jashila Nair, et al.
Publicado: (2022)

Predictors of serum cobalamin and its association with homocysteine in community-dwelling older adults
por: Jungert, Alexandra, et al.
Publicado: (2018)

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes
por: Jax, Thomas, et al.
Publicado: (2017)

Cobalamin Deficiency in the Elderly
por: Marchi, Giacomo, et al.
Publicado: (2020)

Cobalamin deficiency in pregnancy
por: Konings, Heleen, et al.
Publicado: (2021)

Cobalamin Related Parameters and Disease Patterns in Patients with Increased Serum Cobalamin Levels
por: Arendt, Johan F. B., et al.
Publicado: (2012)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy—effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker
por: Xiong, Yingquan, et al.
Publicado: (2022)

The Cobalamin-Binding Protein in Zebrafish Is an Intermediate between the Three Cobalamin-Binding Proteins in Human
por: Greibe, Eva, et al.
Publicado: (2012)

The Conservation of VIT1-Dependent Iron Distribution in Seeds
por: Eroglu, Seckin, et al.
Publicado: (2019)

HGR-ViT: Hand Gesture Recognition with Vision Transformer
por: Tan, Chun Keat, et al.
Publicado: (2023)

The classification of the bladder cancer based on Vision Transformers (ViT)
por: Khedr, Ola S., et al.
Publicado: (2023)

Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial
por: Wanner, Christoph, et al.
Publicado: (2021)

Cobalamin deficiency, hyperhomocysteinemia, and dementia
por: Werder, Steven F
Publicado: (2010)

Nitrosyl- versus nitroxyl-cobalamin?
por: Polaczek, Justyna, et al.
Publicado: (2019)

Incorrect description of mode of excretion of linagliptin
por: Woerle, Hans-Juergen, et al.
Publicado: (2010)

Acute Kidney Injury Associated with Linagliptin
por: Nandikanti, Deepak K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rge9qbd3nfltht2gsu7ae62hkp